EXEL Exelixis

• $1.2M bought by 1 insider
• $35.3M sold by 9 insiders outside a trading plan
• $6.9M sold by 4 insiders under 10b5-1 plans

1. Insider
   Trade
   Value
   Traded, filed
2. Mary C Beckerle Director
   Planned sale
   $527K 9,812 shares at $53.66 38% of stake
   Traded Aug 10 Filed Aug 12
   ↗
3. Jack L Wyszomierski Director
   Planned sale
   $198K 3,925 shares at $50.55 1.4% of stake
   Traded Jun 1 Filed Jun 3
   ↗
4. Sue Gail Eckhardt Director
   Planned sale
   $492K 9,812 shares at $50.14 38% of stake
   Traded Jun 1 Filed Jun 3
   ↗
5. Dana Aftab EVP, Research and Development
   Sale
   $2.2M 43,451 shares at $50.35 6.8% of stake
   Traded May 26 Filed May 28
   ↗
6. Patrick J. Haley EVP, Commercial
   Sale
   $1.6M 32,110 shares at $49.81 8.2% of stake
   Traded May 20 Filed May 22
   ↗
7. Christopher J. Senner CFO
   Sale
   $1.7M 34,901 shares at $50.00 3.5% of stake
   Traded May 18 Filed May 19
   ↗
8. Brenda Hefti SVP and General Counsel
   Planned sale
   $333K 6,625 shares at $50.21 5.8% of stake
   Traded May 18 Filed May 19
   ↗
9. Mary C Beckerle Director
   Sale
   $374K 7,712 shares at $48.45 31% of stake
   Traded May 7 Filed May 8
   ↗
10. Maria C Freire Director
    Sale
    $949K 20,634 shares at $46.00 17% of stake
    Traded May 7 Filed May 8
    ↗
11. George Poste Director
    Sale
    $2.7M 60,000 shares at $45.71 34% of stake
    Traded May 7 Filed May 8
    ↗
12. Dana Aftab EVP, Research and Development
    Sale
    $2.1M 47,918 shares at $44.50 7.2% of stake
    Traded Feb 24 Filed Feb 26
    ↗
13. Dana Aftab EVP, Research and Development
    Sale
    $1.3M 29,873 shares at $44.35 4.3% of stake
    Traded Feb 19 Filed Feb 23
    ↗
14. Jack L Wyszomierski Director
    Planned sale
    $4.4M 99,574 shares at $44.01 26% of stake
    Traded Feb 18 Filed Feb 20
    ↗
15. Julie Smith Director
    Sale
    $4.7M 106,539 shares at $44.00 84% of stake
    Traded Feb 17–18 Filed Feb 19
    ↗
16. Christopher J. Senner CFO
    Sale
    $2.8M 64,895 shares at $43.32 6.2% of stake
    Traded Feb 13–17 Filed Feb 18
    ↗

Also filed in the last 12 months, not counted as buying or selling: 19 stock grants, 16 share withholdings for taxes, 14 gifts, and 9 option exercises.